Patent Yard Sign in
Canadian application, no grantCanada

Drug screening method

CA 2255985 A1 · Owner: Allelix Biopharmaceuticals Inc. · Inventors: Kamboj, Rajender

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A drug screening method is provided wherein a chemical compound to be screened is incubated with a receptor-producing cell to generate a response in the cell. A, referenced agonist is then added to the mixture to elicit a second response. The second, response is then compared with the first response to categorize the chemical compound as, either an agonist, antagonist or potentiator of the receptor.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 14, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 14, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 14, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 14, 1998
GrantedNo grant recorded
Term endedDecember 14, 2018
Patent numberCA 2255985 A1
Classification (IPC)G01N33/56 +1 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedDec 14, 1998Term endedDec 14, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.